700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ ReadersThis Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Department of Medical Oncology
Daniele Santini, Associate Professor, Department of Medical Oncology, Policlinico Universitario, ItalyUniversity “La Sapienza”, Rome, Italy. He graduated cum laude Medicine and Surgery degree from University La Sapienza, Rome, Italy, Graduated cum laude Resident-Specialty in Medical Oncology, PhD in Immunopharmacology.
Design and conduction of phase II-III clinical trials in solid tumours, Chemotherapy in gastrointestinal tumors, Molecular mechanisms on tumor progression, Molecular prognostic and predictive factors in gastrointestinal tumors, Role of bisphosphonates and emerging target theraphies in Osteoncology (denosumab, Src inhibitors, Catepsine K inhibitors, Endothelin A inhibitors, Wnt/dkk agonist/antagonists, TGF beta inhibitors, etc.) Molecular Factors predictive of response to monoclonal antibodies and to tyrosine kinase inhibitors in solid tumours (EGFR inhibitors, Multitarget TKis, Antiangiogenic drugs, mTOR inhibitors, etc).
Global Speakers in the subject
Global Experts in the subject